CVS Health Corp (NYSE:CVS) has a beta value of 0.53 and has seen 1.36 million shares traded in the recent trading session. The company, currently valued at $74.45B, closed the recent trade at $59.17 per share which meant it gained $0.16 on the day or 0.26% during that session. The CVS stock price is -40.7% off its 52-week high price of $83.25 and 10.92% above the 52-week low of $52.71. If we look at the company’s 10-day average daily trading volume, we find that it stood at 11.77 million shares traded. The 3-month trading volume is 11.62 million shares.

The consensus among analysts is that CVS Health Corp (CVS) is Buy stock at the moment, with a recommendation rating of 1.86. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 6 out of 20 have rated it as a Hold, with 14 advising it as a Buy. 0 have rated the stock as Underweight.

CVS Health Corp (NYSE:CVS) trade information

Sporting 0.26% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the CVS stock price touched $59.17 or saw a rise of 1.86%. Year-to-date, CVS Health Corp shares have moved -25.07%, while the 5-day performance has seen it change 4.11%. Over the past 30 days, the shares of CVS Health Corp (NYSE:CVS) have changed 5.18%. Short interest in the company has seen 21.85 million shares shorted with days to cover at 1.65.

Wall Street analysts have a consensus price target for the stock at $105, which means that the shares’ value could jump 43.65% from the levels at last check today. The projected low price target is $63.0 while the price target rests at a high of $127.0. In that case, then, we find that the latest price level in today’s session is -114.64% off the targeted high while a plunge would see the stock gain -6.47% from the levels at last check today.

CVS Health Corp (CVS) estimates and forecasts

Figures show that CVS Health Corp shares have outperformed across the wider relevant industry. The company’s shares have gained 5.58% over the past 6 months, with this year growth rate of -38.56%, compared to -39.10% for the industry.

Earnings growth for 2024 is a modest -38.79% while over the next 5 years, the company’s earnings are expected to decrease by -2.54%.

CVS Dividends

CVS Health Corp is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 2.66 at a share yield of 4.50%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 2.96%.

CVS Health Corp (NYSE:CVS)’s Major holders

Insiders own 0.12% of the company shares, while shares held by institutions stand at 82.92% with a share float percentage of 83.01%. Investors are also buoyed by the number of investors in a company, with CVS Health Corp having a total of 2382.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 116.35 million shares worth more than $6.87 billion. As of 2024-06-30, VANGUARD GROUP INC held 9.2341% of shares outstanding.

The other major institutional holder is BLACKROCK INC., with the holding of over 100.15 million shares as of 2024-06-30. The firm’s total holdings are worth over $5.91 billion and represent 7.9485% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Dodge & Cox Stock Fund and Vanguard Total Stock Market Index Fund. As of Jun 30, 2024, the former fund manager holds about 3.28% shares in the company for having 41.23 shares of worth $2.44 billion while later fund manager owns 39.66 shares of worth $2.35 billion as of Jun 30, 2024, which makes it owner of about 3.15% of company’s outstanding stock.